{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:59:38Z","timestamp":1785380378351,"version":"3.55.0"},"reference-count":184,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The disadvantages of Cisplatin in anticancer treatment are connected to its poor selectivity, resistance developed of cancers to the drug, and its toxicity against normal organs. An important strategy in anticancer treatment is the synthesis and clinical investigation of non-platinum metal complexes with superior anticancer activity and improved selectivity compared to Cisplatin, combined with lower toxicity, fewer side effects and decreased resistance of cancer to the drug. In the current study, we aim to summarize the potential of important non-platinum metal-based organic compounds as therapeutic agents against different cancer cell types. The review covers the general principles of chemotherapy. A literature analysis shows that organic complexes of the metalloids arsenic (As), boron (B), antimony (Sb), and selenium (Se), and of metals, such as Ag, Au, Co, Cu, Fe, Mn, Mo, Ni, Zn, Ce, Ga, Gd, Ir, Os, Pd, Re, Rh, Ru, Ti, and V, have been investigated for potential applications in cancer therapy. This is due to their antiproliferative effects against different cancer types: lung [Cd(II), Co(II), Cu(II), Ni(II), Mn(II), Ru(II), Zn(II)]; breast [Ag(I), Cu(I), Cu(II), Ir(III), Ni(II), Mn(II),. Rh(III), Ru(II)]; gastric [Cu(II), Cu(II)-La(III)]; colon [Ag(I), Cu(II), Ir(III), Pd(II), Rh(III), Ru(II), vanadium(V)]; colorectal [Ag(I), Co(II), Cu(II), Zn(II)]; liver [Ag(I), Co(II), Cu(II), Gd(III), vanadium(V)]; pancreatic [vanadium(IV)]; bladder [Ag(I), Cu(II), Ru(II)]; cervical [Ag(I), Au(I), Cu(I), Cu(II), Fe(II), Ir(III), Rh(III), Ru(II)]; testicular [vanadium(IV)]; prostate [Cu(II), Pd(II), Zn(II)]; leukemia [Ag(I), Co(II), Cu(II), Pd(II), Zn(II)]; sarcoma [Co(II), Ni(II), Zn(II)]; mesothelioma [Cu(II)]; neuroblastoma [Cu(II)]; glioma [Cu(II)]; and melanoma [Au(I), Cu(II), Pd(II), Ru(II)]. The main goals for increasing anticancer metal-based complexes include increasing anticancer activity and selectivity, reducing toxicity, and avoiding cancer cell resistance. Compared to Cisplatin, organocomplexes of copper, ferrocene, and ruthenium are more active. Ruthenium and copper complexes, in particular, are also more selective. Notably, ruthenium and ferrocene derivatives are less toxic than Cisplatin. Lastly, cancers appear to exhibit less resistance against copper, gold, ruthenium, palladium, and ferrocene complexes.<\/jats:p>","DOI":"10.3390\/ph19060925","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:49:42Z","timestamp":1781743782000},"page":"925","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential Activity of Non-Platinum Metal-Based Organic Complexes Against Different Cancer Cell Types"],"prefix":"10.3390","volume":"19","author":[{"given":"Dobrina","family":"Tsvetkova","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University-Sofia, Dunavstr. 2, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefka","family":"Ivanova","sequence":"additional","affiliation":[{"name":"Bulgarian Pharmaceutical Society, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danka","family":"Obreshkova","sequence":"additional","affiliation":[{"name":"Multi-Profile Emergency Department, UMHATEM \u201cN.I. Pirogov\u201d, 1606 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/07357907.2018.1477955","article-title":"Biology of cancer; from cellular cancerogenesis to supracellular evolution of malignant phenotype","volume":"36","author":"Motofei","year":"2018","journal-title":"Cancer Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","article-title":"Tumor suppressor p53 and metabolism","volume":"11","author":"Liu","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"D\u2019Orazi, G., and Cirone, M. (2019). Mutant p53 and cellular stress pathways: A criminal alliance that promotes cancer progression. Cancers, 11.","DOI":"10.3390\/cancers11050614"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.cdd.4401610","article-title":"Carcinogenesis, cancer therapy and chemoprevention","volume":"12","author":"Blagosklonny","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tomasova, K., Cumova, A., Seborova, K., Horak, J., Koucka, K., Vodickova, L., Vaclavikova, R., and Vodicka, P. (2020). DNA repair and ovarian carcinogenesis: Impact on risk, prognosis and therapy outcome. Cancers, 12.","DOI":"10.3390\/cancers12071713"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8549532","DOI":"10.1155\/2022\/8549532","article-title":"Xeroderma pigmentosum: A genetic condition skin cancer correlated\u2014A systematic review","volume":"2022","author":"Brambullo","year":"2022","journal-title":"BioMed Res. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"L61","DOI":"10.1530\/ERC-17-0061","article-title":"KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors","volume":"24","author":"Evenepoel","year":"2017","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Penzo, M., Montanaro, L., Trer\u00e9, D., and Derenzini, M. (2019). The ribosome biogenesis\u2014Cancer connection. Cells, 8.","DOI":"10.3390\/cells8010055"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: New players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11427-016-0018-0","article-title":"The role of ribosomal proteins in the regulation of cell proliferation, tumorigenesis, and genomic integrity","volume":"59","author":"Xu","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"ref_12","first-page":"101","article-title":"Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential","volume":"1825","author":"Montanaro","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Temaj, G., Chichiarelli, S., Eufemi, M., Altieri, F., Hadziselimovic, R., Farooqi, A.A., Yayl\u0131m, \u0130., and Saso, L. (2022). Ribosome-directed therapies in cancer. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092088"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.03.061","article-title":"Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases","volume":"133","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Costa, M., Sezgin-Bayindir, Z., Losada-Barreiro, S., Paiva-Martins, F., Saso, L., and Bravo-D\u00edaz, C. (2021). Polyphenols as antioxidants for extending food shelf-life and in the prevention of health diseases: Encapsulation and interfacial phenomena. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121909"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nadeem, H.R., Akhtar, S., Ismail, T., Sestili, P., Lorenzo, J.M., Ranjha, M.M.A.N., Jooste, L., Hano, C., and Aadil, R.M. (2021). Heterocyclic aromatic amines in meat: Formation, isolation, risk assessment, and inhibitory effect of Plant Extracts. Foods, 10.","DOI":"10.3390\/foods10071466"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djx209","article-title":"Investigation of the relationship between radiation dose and gene mutations and fusions in post-chernobyl thyroid cancer","volume":"110","author":"Efanov","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/em.22370","article-title":"Solar ultraviolet-induced DNA damage response: Melanocytes story in transformation to environmental melanomagenesis","volume":"61","author":"Sarkar","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1038\/sj.onc.1205803","article-title":"Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers","volume":"21","author":"Pfeifer","year":"2002","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vioque, J., Barber, X., Bolumar, F.M.P., Santib\u00e1\u00f1ez, M., de la Hera, M.G., and Moreno-Osset, E. (2008). Esophageal cancer risk by type of alcohol drinking and smoking: A case-control study in Spain. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-221"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41389-020-0202-7","article-title":"Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells","volume":"9","author":"Chandrasekaran","year":"2020","journal-title":"Oncogenesis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3748\/wjg.v19.i10.1508","article-title":"Aflatoxins, hepatocellular carcinoma and public health","volume":"19","author":"Magnussen","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chiavarini, M., Bertarelli, G., Minelli, L., and Fabiani, R. (2017). Dietary intake of meat cooking-related mutagens (HCAs) and risk of colorectal adenoma and cancer: A systematic review and meta-analysis. Nutrients, 9.","DOI":"10.20944\/preprints201705.0079.v1"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","article-title":"Molecular Mechanism of helicobacter pylori-Induced gastric cancer","volume":"52","author":"Alipour","year":"2020","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"D\u00edaz, P., Valderrama, M.V., Bravo, J., and Quest, A.F.G. (2018). Helicobacter pylori and gastric cancer: Adaptive cellular mechanisms involved in disease progression. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00005"},{"key":"ref_26","first-page":"2","article-title":"Oncogenicity of viral hepatitis B and C in the initiation of hepatic cancer stem cells","volume":"5","author":"Sukowati","year":"2019","journal-title":"Hepatoma Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3960\/jslrt.18032","article-title":"Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016","volume":"59","author":"Kawano","year":"2019","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_28","first-page":"287","article-title":"Human papillomavirus tumor infection in esophageal squamous cell carcinoma","volume":"6","author":"Ludmir","year":"2015","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_29","first-page":"186","article-title":"The principles of cancer treatment by chemotherapy","volume":"30","author":"Caley","year":"2012","journal-title":"Surgery"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrclinonc.2014.191","article-title":"The evolution of cancer surgery and future perspectives","volume":"12","author":"Wyld","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Shaw","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/ACI.0000000000000833","article-title":"Management of adverse reactions induced by chemotherapy drugs","volume":"22","author":"Abreu","year":"2022","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3332\/ecancer.2019.961","article-title":"Innovative approaches for cancer treatment: Current perspectives and new challenges","volume":"13","author":"Pucci","year":"2019","journal-title":"ecancermedicalscience"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The gold complex Auranofin: New perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cui, X.Y., Park, S.H., and Park, W.H. (2022). Anti-cancer effects of Auranofin in human lung cancer cells by increasing intracellular ROS levels and depleting GSH levels. Molecules, 27.","DOI":"10.3390\/molecules27165207"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.freeradbiomed.2006.12.021","article-title":"Inhibition of thioredoxin reductase by Auranofin induces apoptosis in Cisplatin-resistant human ovarian cancer cells","volume":"42","author":"Marzano","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"113714","DOI":"10.1016\/j.bcp.2019.113714","article-title":"SK channel activation potentiates auranofin-induced cell death in glio- and neuroblastoma cells","volume":"171","author":"Krabbendam","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2019.01.004","article-title":"Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling","volume":"846","author":"Liu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/sj.leu.2404528","article-title":"Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma","volume":"21","author":"Bonvini","year":"2007","journal-title":"Leukemia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4155\/fmc-2016-0153","article-title":"A survey of the mechanisms of action of anticancer transition metal complexes","volume":"8","author":"Marloye","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2015.06.053","article-title":"N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole substituents related to natural products: Synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes","volume":"101","author":"Maftei","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ccr.2009.02.017","article-title":"The anticancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligands","volume":"253","author":"Sun","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1021\/jm010997w","article-title":"Gold(III) complexes with bipyridyl ligands: Solution chemistry, cytotoxicity, and DNA binding properties","volume":"45","author":"Marcon","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/aoc.1113","article-title":"New cerium(III) and neodymium(III) complexes as cytotoxic agents","volume":"20","author":"Kostova","year":"2006","journal-title":"Appl. Organomet. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.poly.2013.12.035","article-title":"Structural characterization of cobalt(II) complexes of an N,O donor schiff base and their activity on carcinoma cells","volume":"71","author":"Das","year":"2014","journal-title":"Polyhedron"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11243-024-00630-6","article-title":"Exploring the therapeutic potential of copper and cobalt complexes as anticancer agents: A comprehensive review","volume":"50","author":"Unavane","year":"2025","journal-title":"Transit. Met. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0960-894X(94)00465-R","article-title":"Tricarbonyl \u03b76 arene chromium(0) based antitumor agents","volume":"5","author":"Jones","year":"1995","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.saa.2013.09.142","article-title":"Synthesis, interaction with DNA and antiproliferative activities of two novel Cu(II) complexes with schiff base of benzimidazoles","volume":"121","author":"Song","year":"2014","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biomaterials.2015.08.031","article-title":"Cellular localization of iron(II) polypyridyl complexes determines their anticancer action mechanisms","volume":"71","author":"Chen","year":"2015","journal-title":"Biomaterials"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lange, T.S., Kim, K.K., Singh, R.K., Strongin, R.M., McCourt, C.K., and Brard, L. (2008). Iron(III)-salophene: An organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells. PLoS ONE, 3.","DOI":"10.1371\/annotation\/d97d24fc-aa07-40fd-88b2-6b2e050ddb31"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/zaac.201300055","article-title":"Biological activity of molybdenum(II) allyl dicarbonyl complexes with N-N coligands of variable aromatic surface area on adherent and non-adherent human cancer cells","volume":"639","author":"Pfeiffer","year":"2013","journal-title":"Z. Anorg. Allg. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.saa.2015.05.063","article-title":"Synthesis, crystal structures, photoluminescence properties and DNA binding of triazine nickel(II) complexes for DNA detection","volume":"151","author":"Duan","year":"2015","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1039\/c3dt33077j","article-title":"Zinc(II) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells","volume":"42","author":"Liu","year":"2013","journal-title":"Dalton Trans."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e5594","DOI":"10.1002\/aoc.5594","article-title":"Anticancer activity of lanthanum(III) and europium(III) 5-Fluorouracil complexes on Caco-2 cell line","volume":"34","author":"Wahman","year":"2020","journal-title":"Appl. Organomet. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1039\/C8DT01858H","article-title":"Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium","volume":"47","author":"Konkankit","year":"2018","journal-title":"Dalton Trans."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chu, W.K., Rono, C.K., and Makhubela, B.C.E. (2022). New triazolyl N^N bidentate Rh(III), Ir(III), Ru(II) and Os(II) complexes: Synthesis and characterization, probing possible relations between cytotoxicity with transfer hydrogenation efficacy and interaction with model biomolecules. Molecules, 27.","DOI":"10.3390\/molecules27072058"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccr.2015.11.004","article-title":"New trends in platinum and palladium complexes as antineoplastic agents","volume":"310","author":"Fanelli","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"M\u00e1likov\u00e1, K., Masaryk, L., and \u0160tarha, P. (2021). Anticancer half-sandwich rhodium(III) complexes. Inorganics, 9.","DOI":"10.3390\/inorganics9040026"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II) compounds: Next-generation anticancer metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/ejoc.201600943","article-title":"Ru(III) complexes for anticancer therapy: The importance of being nucleolipidic","volume":"2017","author":"Riccardi","year":"2017","journal-title":"Eur. J. Org. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1389557043487565","article-title":"Antitumor titanium compounds","volume":"4","author":"Caruso","year":"2004","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccr.2015.03.010","article-title":"The chemistry and biology of vanadium compounds in cancer therapeutics","volume":"301\u2013302","author":"Kioseoglou","year":"2015","journal-title":"Coord. Chem. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.2174\/0929867325666180914104237","article-title":"Novel chemotherapeutic agents\u2014The contribution of Scorpionates","volume":"26","author":"Andrade","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.poly.2017.09.041","article-title":"Luminescent Ag(I) scorpionates based on tris(2-pyridyl)phosphine oxide: Synthesis and cytotoxic activity evaluation","volume":"138","author":"Artemev","year":"2017","journal-title":"Polyhedron"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2012.11.022","article-title":"Neutral and charged phosphine\/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity","volume":"59","author":"Porchia","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/adsc.200700529","article-title":"Half-sandwich scorpionate vanadium, iron and copper complexes: Synthesis and application in the catalytic peroxidative oxidation of cyclohexane under mild conditions","volume":"350","author":"Silva","year":"2008","journal-title":"Adv. Synth. Catal."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"110881","DOI":"10.1016\/j.jinorgbio.2019.110881","article-title":"Zn(II) and Co(II) derivatives anchored with scorpionate precursor: Antiproliferative evaluation in human cancer cell lines","volume":"202","author":"Das","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.tet.2015.03.002","article-title":"Synthesis and characterization of heteroscorpionate-based manganese carbonyl complexes as CO-releasing molecules","volume":"71","author":"Strinitz","year":"2015","journal-title":"Tetrahedron"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2004550","DOI":"10.1002\/adfm.202004550","article-title":"Pulmonary targeting crosslinked cyclodextrin metal\u2013organic frameworks for lung cancer therapy","volume":"31","author":"He","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: Lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung vancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann. Glob. Health"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"725","DOI":"10.17219\/acem\/68631","article-title":"Multiple primary lung cancer: A literature review","volume":"27","author":"Romaszko","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e6623","DOI":"10.1002\/aoc.6623","article-title":"Synthesis, characterization, molecular docking, biological activity, and DNA cleavage studies of Cu(II), Co(II), Ni(II), Mn(II), and Cd(II) schiff base complexes","volume":"36","author":"Diab","year":"2022","journal-title":"Appl. Organomet. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ejmech.2009.12.048","article-title":"A novel copper complex of salicylaldehyde pyrazole hydrazone induces apoptosis through up-regulating integrin \u03b24 in H322 lung carcinoma cells","volume":"45","author":"Fan","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1021\/acs.jmedchem.9b02000","article-title":"Structurally strained half-sandwich iridium(III) complexes as highly potent anticancer agents","volume":"63","author":"Carrasco","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jorganchem.2019.04.003","article-title":"Cytotoxicity of cationic NHC copper(I) complexes coordinated to 2,2\u2032-bis-pyridyl ligands","volume":"893","author":"Elie","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejmech.2013.05.048","article-title":"Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands","volume":"66","author":"Chelopo","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00775-019-01644-7","article-title":"6-Methoxyquinoline complexes as lung carcinoma agents: Induction of oxidative damage on A549 monolayer and multicellular spheroid model","volume":"24","author":"Ruiz","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/jcp.24385","article-title":"Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells","volume":"288","author":"Strianese","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1039\/D1DT03749H","article-title":"Discovery of thirteen cobalt(II) and copper(II) salicylaldehyde schiff base complexes that induce apoptosis and autophagy in human lung adenocarcinoma A549\/DDP cells and that can overcome cisplatin resistance in vitro and in vivo","volume":"51","author":"Chen","year":"2022","journal-title":"Dalton Trans."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1039\/D2DT00669C","article-title":"A new class of nickel(II) oxyquinoline\u2013bipyridine complexes as potent anticancer agents induces apoptosis and autophagy in A549\/DDP tumor cells through mitophagy pathways","volume":"55","author":"Wang","year":"2022","journal-title":"Dalton Trans."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00775-020-01835-7","article-title":"The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes against non-small-cell lung cancer and triple negative breast cancer cells","volume":"26","author":"Fayad","year":"2021","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.poly.2017.01.008","article-title":"Synthesis and structural characterization of a vanadium(V)-pyridylbenzimidazole complex: DNA binding and anticanceractivity","volume":"126C","author":"Mal","year":"2017","journal-title":"Polyhedron"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Xu, S., Liu, Y., Zhang, T., Zheng, J., Lin, W., Cai, J., Zou, J., Chen, Y., Xie, Y., and Chen, Y. (2021). The global, regional, and national burden and trends of breast cancer from 1990 to 2019: Results from the global burden of disease study 2019. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.689562"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Zahedi, R., Vardanjani, H.M., Baneshi, M.R., Haghdoost, A.A., Afshar, R.M., Sarabi, R.E., Tavakoli, F., and Zolala, F. (2020). Incidence Incidence trend of breast cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis. BMC Women\u2019s Health, 20.","DOI":"10.1186\/s12905-020-00903-z"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14498","DOI":"10.1039\/D1DT02909F","article-title":"Metal complexes against breast cancer stem cells","volume":"50","author":"Li","year":"2021","journal-title":"Dalton Trans."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jinorgbio.2014.02.013","article-title":"Promising antioxidant and anticancer (human breast cancer) oxidovanadium(IV)complex of chlorogenic acid. synthesis, characterization and spectroscopic examination on the transportmechanism with bovine serum albumin","volume":"135C","author":"Naso","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1021\/ic100944d","article-title":"Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: Synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells","volume":"49","author":"Balakrishna","year":"2010","journal-title":"Inorg. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"110975","DOI":"10.1016\/j.jinorgbio.2019.110975","article-title":"Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres","volume":"204","author":"Balsa","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1021\/acs.inorgchem.0c02932","article-title":"Copper(II) N,N,O-chelating complexes as potential anticancer agents","volume":"60","author":"Sciortino","year":"2021","journal-title":"Inorg. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e4526","DOI":"10.1002\/aoc.4526","article-title":"Synthesis, characterization and in vitro anticancer, DNA binding and cleavage studies of Mn(II), Co(II), Ni(II) and Cu(II) complexes of Schiff base ligand 3-(2-(1-(1H-benzimidazol-2-yl)ethylidene)hydrazinyl quinoxalin-2(1H)-one and crystal structure of the ligand","volume":"32","author":"Sukanya","year":"2018","journal-title":"Appl. Organomet. Chem."},{"key":"ref_94","first-page":"797","article-title":"Synthesis, characterization and biological evaluation of heterocyclic triazole derived schiff base ligands comprising Mn(II) complexes: Implications of their DNA\/protein binding docking and anticancer activity studies","volume":"60","author":"Sangeetha","year":"2021","journal-title":"Ind. J. Chem. Sect. A"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/anie.201803868","article-title":"Polyoxometalates as potential next-generation metallodrugs in the combat against cancer","volume":"58","author":"Bijelic","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/14756366.2018.1530994","article-title":"Synthesis and cytotoxic activities of novel copper and silver complexes of 1,3-diaryltriazene-substituted sulfonamides","volume":"34","author":"Canakci","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1021\/acs.jmedchem.5b00455","article-title":"Hypoxia-sensitive metal \u03b2-ketoiminato complexes showing induced single-strand DNA breaks and cancer cell death by apoptosis","volume":"58","author":"Lord","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1021\/jm5012337","article-title":"In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer","volume":"57","author":"Frik","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"11533","DOI":"10.1039\/c3cc46239k","article-title":"On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes","volume":"49","author":"Yellol","year":"2013","journal-title":"Chem. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"110870","DOI":"10.1016\/j.jinorgbio.2019.110870","article-title":"Pt(II) and Pd(II) complexes with a thiazoline derivative ligand: Synthesis, structural characterization, antiproliferative activity and evaluation of pro-apoptotic ability in tumor cell lines HT-29 and U-937","volume":"202","author":"Franco","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.3390\/ijms13089649","article-title":"Selenium compounds, apoptosis and other types of cell death: An overview for cancer therapy","volume":"13","author":"Plano","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","article-title":"Global burden of oesophageal and gastric cancer by histology and subsite in 2018","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","article-title":"Updates on management of gastric cancer","volume":"21","author":"Johnston","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/zaac.201800158","article-title":"A new heterometallic CuII-LaIII metal-organic framework: Crystal structure, adsorption of light hydrocarbons and anti-gastric cancer activity","volume":"644","author":"Zhang","year":"2018","journal-title":"Z. Anorg. Allg. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Sawicki, T., Ruszkowska, M., Danielewicz, A., Nied\u017awiedzka, E., Ar\u0142ukowicz, T., and Przyby\u0142owicz, K.E.A. (2021). Review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers, 13.","DOI":"10.3390\/cancers13092025"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"106092","DOI":"10.1016\/j.ejps.2021.106092","article-title":"Antiproliferative activity of two copper(II) complexes on colorectal cancer cell models: Impact on ROS production, apoptosis induction and NF-\u03baB inhibition","volume":"169","author":"Ruiz","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1039\/D1NJ00040C","article-title":"Interaction, binding capacity and anticancer properties of N,N\u2032-bis (acetylacetone)-propylenediimine-copper (II) on colorectal cancer cell line Caco-2","volume":"45","year":"2021","journal-title":"N. J. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/00958972.2018.1461848","article-title":"Anti-cancer diaminotris (phenolato) vanadium(V) complexes: Ligand-metal interplay","volume":"71","author":"Reytman","year":"2018","journal-title":"J. Coord. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/c2dt11577h","article-title":"Cobalt complexes bearing scorpionate ligands: Synthesis, characterization, cytotoxicity and DNA cleavage","volume":"41","author":"Silva","year":"2012","journal-title":"Dalton Trans."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/chem.201903605","article-title":"The first anticancer tris(pyrazolyl)borate molybdenum(IV) complexes: Tested in vitro and in vivo\u2014A comparison of O,O-, S,O-, and N,N-chelate effects","volume":"26","author":"Berasaluce","year":"2020","journal-title":"Chem. Eur. J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1038\/cddis.2013.185","article-title":"A novel osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma","volume":"4","author":"Maillet","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.biopha.2017.05.108","article-title":"Induction of apoptosis in human colorectal cancer cell line, HCT-116 by a vanadium-schiffbase complex","volume":"92","author":"Sinha","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8849568","DOI":"10.1155\/2021\/8849568","article-title":"Synthesis and biological acreening of new 4-hydroxycoumarin serivatives and their palladium(II) complexes","volume":"2021","author":"Avdovic","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: Connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Ann. Rev. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2621863","DOI":"10.1155\/2021\/2621863","article-title":"Magnetic property and therapeutic effect of a new Co(II) complex on liver cancer by regulating the expression of miRNA31","volume":"2021","author":"Guo","year":"2021","journal-title":"Int. J. Polym. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e05644","DOI":"10.1002\/slct.202505644","article-title":"Pd(II) Complexes of schiff base ligands derived from 4-aminoantipyrine: Synthesis, characterization, crystal structure and acute toxicity evaluation","volume":"11","author":"Shova","year":"2026","journal-title":"ChemistrySelect"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10534-006-9008-0","article-title":"Copper-1,10-phenanthroline-induced apoptosis in liver carcinoma Bel-7402 cells associates with copper overload, reactive oxygen species production, glutathione depletion and oxidative DNA damage","volume":"20","author":"Cai","year":"2007","journal-title":"BioMetals"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11243-017-0150-z","article-title":"A vanadium(V) terpyridine complex: Synthesis, characterization, cytotoxicity in vitro and induction of apoptosis in cancer cells","volume":"42","author":"Hong","year":"2017","journal-title":"Transit. Met. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Stryjska, K., Radko, L., Ch\u0119ci\u0144ska, L., Kusz, J., Posyniak, A., and Ochocki, J. (2020). Synthesis, spectroscopy, light stability, single-crystal analysis, and in vitro cytotoxic activity on HepG2 liver cancer of two novel silver(I) complexes of Miconazole. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103629"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/aoc.3434","article-title":"1,2,4-triazole-based N-heterocyclic carbene complexes of gold(I): Synthesis, characterization and biological activity","volume":"30","author":"Turek","year":"2016","journal-title":"Appl. Organomet. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"45229","DOI":"10.1038\/srep45229","article-title":"Heteroleptic copper(I) complexes of \u201cscorpionate\u201d bis-pyrazolyl carboxylate ligand with auxiliary phosphine as potential anticancer agents: An insight into cytotoxic mode","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.1039\/C5DT02101D","article-title":"Advances in cobalt complexes as anticancer agents","volume":"44","author":"Munteanu","year":"2015","journal-title":"Dalton Trans."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00775-008-0387-2","article-title":"Vanadyl bisacetylacetonate induced G1\/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells","volume":"13","author":"Fu","year":"2008","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1039\/C5MT00010F","article-title":"Ruthenium complex L-WH0402 induces hepatocellular carcinoma LM6 (HCCLM6) cell death by triggering the Beclin-1-dependent autophagy pathway","volume":"7","author":"Yuan","year":"2015","journal-title":"Metallomics"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Lu, Y., Shen, T., Yang, H., and Gu, W. (2016). Ruthenium complexes Induce HepG2 human hepatocellular carcinoma cell apoptosis and inhibit cell migration and invasion through regulation of the Nrf2 pathway. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050775"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: Understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Kowalski, S., Wyrzykowski, D., Hac, S., Rychlowski, M., Radomski, M.W., and Inkielewicz-Stepniak, I. (2019). New oxidovanadium(IV) coordination complex containing 2-methylnitrilotriacetate ligands induces cell cycle arrest and autophagy in human pancreatic ductal adenocarcinoma cell lines. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020261"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00775-016-1389-0","article-title":"Bis (acetylacetonato)-oxidovanadium(IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK\/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells","volume":"21","author":"Wu","year":"2016","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41598-018-19199-z","article-title":"The global epidemiology of bladder cancer: A joinpoint regression analysis of its incidence and mortality trends and projection","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.poly.2015.03.029","article-title":"A diversity of hydrogen bond motifs in the crystal structures of nickel(II) and copper(II) complexes with N-arylalkyliminodiacetamides","volume":"93","author":"Kukovec","year":"2015","journal-title":"Polyhedron"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ica.2019.01.013","article-title":"Copper(II) complexes with N\u2032-methylsarcosinamide selective for human bladder cancer cells","volume":"488","author":"Kukovec","year":"2019","journal-title":"Inorg. Chim. Acta"},{"key":"ref_133","first-page":"26","article-title":"A retrospective study of the epidemiology and histological subtypes of ovarian epithelial neoplasms at Charlotte Maxeke Johannesburg Academic Hospital","volume":"13","author":"Pillay","year":"2021","journal-title":"S. Afr. J. Gynaecol. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer. US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Maoz, A., Matsuo, K., Ciccone, M.A., Matsuzaki, S., Klar, M., Roman, L.D., Sood, A.K., and Gershenson, D.M. (2020). Molecular pathways and targeted therapies for malignant ovarian germ cell tumors and sex cord\u2013stromal tumors: A contemporary review. Cancers, 12.","DOI":"10.3390\/cancers12061398"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Wang, H., Qiu, Z., Liu, H., Jayawardhana, A.M.D.S., Yue, Z., Daghlas, H., Bowers, D.J., Datta, B., and Zheng, Y.-R. (2019). Nanoparticles of metal-organic cages overcoming drug resistance in ovarian cancer. Front. Chem., 7.","DOI":"10.3389\/fchem.2019.00039"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"18534","DOI":"10.1002\/chem.201503656","article-title":"Dinuclear gold(I) pyrrolidinedithiocarbamato complex: Cytotoxic and antimigratory activities on cancer cells and the use of metal\u2013organic framework","volume":"21","author":"Sun","year":"2015","journal-title":"Chem. Eur. J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"214506","DOI":"10.1016\/j.ccr.2022.214506","article-title":"Revisiting metallodrugs for the treatment of skin cancers","volume":"462","author":"Manzano","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1039\/c9mt00055k","article-title":"Mixed copper(II)-phenanthroline complexes induce cell death of ovarian cancer cells by evoking the unfolded protein response","volume":"11","author":"Pivetta","year":"2019","journal-title":"Met. Integr. Biometal Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1021\/jm060857s","article-title":"Ovarian cancer activity of cyclic amine and thiaether metal complexes","volume":"50","author":"Medvetz","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jinorgbio.2016.11.010","article-title":"Evaluation of cellular uptake, cytotoxicity and cellular ultrastructural effects of heteroleptic oxidovanadium(IV) complexes of salicylaldimines and polypyridyl ligands","volume":"166","author":"Scalese","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1002\/cncr.33795","article-title":"Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years","volume":"127","author":"Lin","year":"2021","journal-title":"Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/mp400592n","article-title":"Oxidativestress induced by copper and ironcomplexeswith 8-hydroxyquinoline derivatives causes paraptotic death of HeLa cancercells","volume":"11","author":"Barilli","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1021\/acs.jmedchem.5b00855","article-title":"Synthesis, anticancer activity, and genome profiling of thiazolo arene ruthenium complexes","volume":"58","author":"Grozav","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejmech.2018.05.023","article-title":"Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2\u2032-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism","volume":"154","author":"Qi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_146","first-page":"1536","article-title":"Apoptosis-inducing vanadocene compounds against human testicular cancer","volume":"6","author":"Ghosh","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMra1701695","article-title":"Metastatic prostate cancer","volume":"378","author":"Sartor","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mnfr.200700511","article-title":"International epidemiology of prostate cancer: Geographical distribution and secular trends","volume":"53","author":"Baade","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2017.03.016","article-title":"An anti-prostate cancer complex as a dual inhibitor of STAT3 and NF-kB","volume":"396","author":"Kang","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/j.arabjc.2019.08.002","article-title":"A mononuclear copper(II) complex containing benzimidazole and pyridyl ligands: Synthesis, characterization, and antiproliferative activity against human cancer cells","volume":"13","author":"Kacar","year":"2020","journal-title":"Arab. J. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1021\/jm060712l","article-title":"Novel schiff base copper complexes of quinoline-2-carboxaldehyde as proteasome inhibitors in human prostate cancer cells","volume":"49","author":"Adsule","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ijc.25311","article-title":"Antitumor activity of gold (III)-dithiocarbamato derivatives on prostate cancer cells and xenografts","volume":"128","author":"Cattaruzza","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/jm801276a","article-title":"Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells","volume":"52","author":"Valentini","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1097\/HS9.0000000000000468","article-title":"Chronic myeloid Leukemia in 2020","volume":"4","author":"Hehlmann","year":"2020","journal-title":"Hemasphere"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"16745","DOI":"10.1038\/s41598-020-73488-0","article-title":"Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells","volume":"10","author":"Espino","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"35625","DOI":"10.1039\/C8RA07463A","article-title":"Theoretical and experimental investigation of anticancer activities of an acyclic and symmetrical compartmental schiff base ligand and its Co(II), Cu(II) and Zn(II) complexes","volume":"8","author":"Saghatforoush","year":"2018","journal-title":"RSC Adv."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jinorgbio.2007.12.011","article-title":"Copper(II) complexes with Sparfloxacin and nitrogen-donor heterocyclic ligands: Structure\u2013activity relationship","volume":"102","author":"Efthimiadou","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1200\/JCO.2017.75.1743","article-title":"Osteosarcoma, chondrosarcoma, and chordoma","volume":"36","author":"Whelan","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Chawla, S.P., Pang, S.S., Jain, D., Jeffrey, S., Chawla, N.S., Song, P.Y., Hall, F.L., and Gordon, E.M. (2025). Gene and cell therapy for sarcomas: A review. Cancers, 17.","DOI":"10.3390\/cancers17071125"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10534-017-0001-6","article-title":"Characterization and cytotoxic effect of aqua-(2,2\u2032,2\u2033-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells","volume":"30","author":"Tesmar","year":"2017","journal-title":"BioMetals"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1071\/CH18287","article-title":"An adeninate-based metal\u2013organic framework for antitumour drug delivery and anti-osteogenic sarcoma activity evolution","volume":"71","author":"Yan","year":"2018","journal-title":"Aust. J. Chem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molstruc.2019.04.081","article-title":"Two polypyridyl-chelating nickel(II) and copper(II) complexes: Synthesis, structural characterization and in vitro anticancer activity in osteogenic sarcoma","volume":"1191","author":"Cui","year":"2019","journal-title":"J. Mol. Struct."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"13169","DOI":"10.1039\/C7NJ04799A","article-title":"Comparative studies of schiff base-copper(II) and zinc(II) complexes regarding their DNA binding ability and cytotoxicity against sarcoma cells","volume":"42","author":"Vieira","year":"2018","journal-title":"N. J. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jinorgbio.2015.03.011","article-title":"Cis-[RuCl(BzCN)(N\u2013N)(P\u2013P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N\u2013N=2,2\u2032-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1\u2032-(diphenylphosphino)ferrocene)","volume":"149","author":"Pereira","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant mesothelioma and its non-asbestos causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jinorgbio.2007.12.033","article-title":"Double-strand DNA cleavage induced by oxindole-schiff base copper(II) complexes with potential antitumor activity","volume":"102","author":"Luz","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Campagna, R., Bacchetti, T., Salvolini, E., Pozzi, V., Molinelli, E., Brisigotti, V., Sartini, D., Campanati, A., Ferretti, G., and Offidani, A. (2020). Paraoxonase-2 silencing enhances sensitivity of A375 melanoma cells to treatment with Cisplatin. Antioxidants, 9.","DOI":"10.3390\/antiox9121238"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jinorgbio.2017.05.010","article-title":"Antitumoral effect of vanadium compounds in malignant melanoma cell lines","volume":"174","author":"Rozzo","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jinorgbio.2013.07.038","article-title":"Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cells","volume":"127","author":"Spoerlein","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/php.13177","article-title":"Synthesis and characterization of Ru(II) complexes with \u03c0-expansive imidazophen ligands for the photokilling of human melanoma cells","volume":"96","author":"Ghosh","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.1021\/ic201714c","article-title":"Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes","volume":"50","author":"Pettinari","year":"2011","journal-title":"Inorg. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e202302094","DOI":"10.26508\/lsa.202302094","article-title":"A new ferrocene derivative blocks K-Ras localization and function by oxidative modification at His95","volume":"6","author":"Rehl","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12964-024-01726-3","article-title":"The crosstalk between copper-induced oxidative stress and cuproptosis: A novel potential anticancer paradigm","volume":"22","author":"Vo","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"215169","DOI":"10.1016\/j.ccr.2023.215169","article-title":"An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents","volume":"487","author":"Bashir","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/ja027719m","article-title":"Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: Novel recognition mechanisms","volume":"125","author":"Chen","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12935-025-03864-1","article-title":"Cuproptosis: A novel therapeutic mechanism in lung cancer","volume":"25","author":"Luo","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_178","first-page":"17663","article-title":"Cuproptosis as the new kryptonite of cancer: A copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma","volume":"149","author":"Ozkan","year":"2023","journal-title":"Cancer Res. Clin. Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"759","DOI":"10.32604\/or.2024.057019","article-title":"Metal-based molecules in the treatment of cancer: From bench to bedside","volume":"33","author":"Bernal","year":"2025","journal-title":"Oncol. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chem therapy drugs: A review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jinorgbio.2016.09.015","article-title":"New copper(I) complexes bearing Lomefloxacin motif: Spectroscopic properties, in vitro cytotoxicity and interactions with DNA and human serum albumin","volume":"165","author":"Komarnicka","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"112109","DOI":"10.1016\/j.ejmech.2020.112109","article-title":"Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships","volume":"190","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-03-0746","article-title":"A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent","volume":"10","author":"Pluim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2174\/1568026621666210728093527","article-title":"The antiproliferative activity of Ferrocene derivatives against drug-resistant cancer cell lines: A mini review","volume":"21","author":"Li","year":"2021","journal-title":"Curr. Top. Med. Chem."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/925\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:57:14Z","timestamp":1781744234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":184,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ph19060925"],"URL":"https:\/\/doi.org\/10.3390\/ph19060925","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}